Clinical Trials Logo

Bird Flu clinical trials

View clinical trials related to Bird Flu.

Filter by:
  • None
  • Page 1

NCT ID: NCT01675284 Completed - Avian Influenza Clinical Trials

A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine

Start date: August 2012
Phase: Phase 1
Study type: Interventional

The focus of this study is to evaluate the safety, reactogenicity and humoral immune responses of the study vaccine when administered at the dose of 7.5 µg HA, 15 µg HA, or 30 µg HA to human subjects.

NCT ID: NCT01335347 Completed - Avian Influenza Clinical Trials

Safety Study of an Oral Vaccine to Prevent Avian Influenza

H5N1
Start date: April 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to demonstrate the safety and immunogenicity of an oral vaccine to prevent avian influenza. Volunteers will receive either one or two doses of research vaccine or placebo as part of this study.

NCT ID: NCT01006798 Completed - Influenza Clinical Trials

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Start date: October 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the safety and immunogenicity over a 9-month period of five different dosages of Ad4-H5-Vtn in volunteers (Vaccinees) who receive three doses of the study vaccine or placebo. In addition, transmission of Ad4-H5-Vtn will be evaluated in all Household Contacts residing with the vaccinated volunteers. Vaccinees also may participate in a substudy in which they receive a booster vaccination with the licensed Influenza Virus Vaccine, H5N1 (Sanofi Pasteur).